From crisis to cure: Allogeneic stem cell transplantation for adults with sickle cell disease

ER Dovern

From crisis to cure: Allogeneic stem cell transplantation for adults with sickle cell disease

ER Dovern

Research output: PhD Thesis › Phd-Thesis - Research and graduation internal

Abstract

Sickle cell disease (SCD) is a group of inherited hemoglobinopathies, associated with chronic hemolytic anemia, recurrent vaso-occlusive pain episodes, and progressive organ damage. To date, allogeneic hematopoietic stem cell transplantation (HSCT) is the only established curative treatment for patients with SCD. Historically, HSCT was used in children with severe SCD and

Original language	English
Qualification	Doctor of Philosophy
Awarding Institution	Universiteit van Amsterdam
Supervisors/Advisors	Biemond, Bart, Supervisor Fijnvandraat, Karin, Supervisor Nur, Erfan, Co-supervisor
Award date	9 Oct 2025
Print ISBNs	9789465224978
Publication status	Published - 2025

Access to Document

https://hdl.handle.net/11245.1/536f15e9-6f2e-475a-b942-2dfa5a669000

Cite this

@phdthesis{a1acc12c41fd430190fd37bcd416434e,

title = "From crisis to cure: Allogeneic stem cell transplantation for adults with sickle cell disease",

abstract = "Sickle cell disease (SCD) is a group of inherited hemoglobinopathies, associated with chronic hemolytic anemia, recurrent vaso-occlusive pain episodes, and progressive organ damage. To date, allogeneic hematopoietic stem cell transplantation (HSCT) is the only established curative treatment for patients with SCD. Historically, HSCT was used in children with severe SCD and",

author = "ER Dovern",

year = "2025",

language = "English",

isbn = "9789465224978",

type = "Phd-Thesis - Research and graduation internal",

school = "Universiteit van Amsterdam",

}

TY - THES

T1 - From crisis to cure

T2 - Allogeneic stem cell transplantation for adults with sickle cell disease

AU - Dovern, ER

PY - 2025

Y1 - 2025

N2 - Sickle cell disease (SCD) is a group of inherited hemoglobinopathies, associated with chronic hemolytic anemia, recurrent vaso-occlusive pain episodes, and progressive organ damage. To date, allogeneic hematopoietic stem cell transplantation (HSCT) is the only established curative treatment for patients with SCD. Historically, HSCT was used in children with severe SCD and

AB - Sickle cell disease (SCD) is a group of inherited hemoglobinopathies, associated with chronic hemolytic anemia, recurrent vaso-occlusive pain episodes, and progressive organ damage. To date, allogeneic hematopoietic stem cell transplantation (HSCT) is the only established curative treatment for patients with SCD. Historically, HSCT was used in children with severe SCD and

M3 - Phd-Thesis - Research and graduation internal

SN - 9789465224978

ER -

From crisis to cure: Allogeneic stem cell transplantation for adults with sickle cell disease

Abstract

Access to Document

Fingerprint

Cite this